Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trial

Diacylglyceride acyltransferase 1 (DGAT1) is the enzyme that adds the final fatty acid on to a diacylglyceride during triglyceride (TG) synthesis. DGAT1 plays a key role in the repackaging of dietary TG into circulating TG rich chylomicrons. A growing amount of research has indicated that an exagger...

Full description

Saved in:
Bibliographic Details
Published in:Nutrition & metabolism 2015-08, Vol.12 (1), p.27-27, Article 27
Main Authors: Velliquette, Rodney A, Grann, Kerry, Missler, Stephen R, Patterson, Jennifer, Hu, Chun, Gellenbeck, Kevin W, Scholten, Jeffrey D, Randolph, R Keith
Format: Article
Language:English
Subjects:
Anthocyanin
Care and treatment
Clinical trials
Health aspects
Instrument industry
Medical research
Medicine, Botanic
Medicine, Experimental
Medicine, Herbal
Metabolism
Monounsaturated fatty acids
Nutrition
Obesity
Physiological aspects
Plant metabolites
Polyphenols
Triglycerides
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c528t-b104919f667f6ac15f9417b2da55a5c53a9b7b76c9f4ee1678828279ae3f9d533
cites cdi_FETCH-LOGICAL-c528t-b104919f667f6ac15f9417b2da55a5c53a9b7b76c9f4ee1678828279ae3f9d533
container_end_page 27
container_issue 1
container_start_page 27
container_title Nutrition & metabolism
container_volume 12
creator Velliquette, Rodney A
Grann, Kerry
Missler, Stephen R
Patterson, Jennifer
Hu, Chun
Gellenbeck, Kevin W
Scholten, Jeffrey D
Randolph, R Keith
description Diacylglyceride acyltransferase 1 (DGAT1) is the enzyme that adds the final fatty acid on to a diacylglyceride during triglyceride (TG) synthesis. DGAT1 plays a key role in the repackaging of dietary TG into circulating TG rich chylomicrons. A growing amount of research has indicated that an exaggerated postprandial circulating TG level is a risk indicator for cardiovascular and metabolic disorders. The aim of this research was to identify a botanical extract that inhibits intestinal DGAT1 activity and attenuates postprandial hypertriglyceridemia in overweight and obese humans. Twenty individual phytochemicals and an internal proprietary botanical extract library were screened with a primary cell-free DGAT1 enzyme assay that contained dioleoyl glycerol and palmitoleoyl Coenzyme A as substrates plus human intestinal microsomes as the DGAT1 enzyme source. Botanical extracts with IC50 values 
doi_str_mv 10.1186/s12986-015-0025-2
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4526202</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A541532863</galeid><sourcerecordid>A541532863</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-b104919f667f6ac15f9417b2da55a5c53a9b7b76c9f4ee1678828279ae3f9d533</originalsourceid><addsrcrecordid>eNptkl1rFDEUhgdRbK3-AG8k4I1CpyaZSTJzUyjFj4WC4Md1yORje0o2WZPs4vrj_G1m3Fq7InOR5JznPcm8vE3znOAzQgb-JhM6DrzFhLUYU9bSB80xEX3XCizYw3v7o-ZJzjcYd10_4sfNEeW050PPjpufC2NDAQdaFYgBRYcUmmJRoVY8gnANE5SY5gaEYnOBUOsGlN75pd9pm8BYNJ9KUiE7m1S2iNRKgS2UHdqCqsq6lBRR1snaAGGJVDD1prVKynvrT1EVm7iCH9acoslDMPNm7ZW2U2x1DFVdQYN07f1-Wkmg_NPmkVM-22e360nz9d3bL5cf2quP7xeXF1etZnQo7URwP5LRcS4cV5owN_ZETNQoxhTTrFPjJCbB9eh6awkXw0AHKkZlOzca1nUnzfl-7nozrazR1bP6cLlOsFJpJ6MCedgJcC2XcSt7Vr3GtA54dTsgxW-baqNcQdbWexVs3GRJBKa8Hzmd0Zf_oDdxk6rrMzVgLjohur_UUnkrIbhY79XzUHnBesI6OvCZOvsPVT9jV1BdtQ5q_UDw-kAwO2-_l6Xa5CwXnz8dsmTP6hRzTtbd-UGwnAMq9wGVNaByDqicf-7FfSPvFH8S2f0CPKXjog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780673773</pqid></control><display><type>article</type><title>Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trial</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Velliquette, Rodney A ; Grann, Kerry ; Missler, Stephen R ; Patterson, Jennifer ; Hu, Chun ; Gellenbeck, Kevin W ; Scholten, Jeffrey D ; Randolph, R Keith</creator><creatorcontrib>Velliquette, Rodney A ; Grann, Kerry ; Missler, Stephen R ; Patterson, Jennifer ; Hu, Chun ; Gellenbeck, Kevin W ; Scholten, Jeffrey D ; Randolph, R Keith</creatorcontrib><description>Diacylglyceride acyltransferase 1 (DGAT1) is the enzyme that adds the final fatty acid on to a diacylglyceride during triglyceride (TG) synthesis. DGAT1 plays a key role in the repackaging of dietary TG into circulating TG rich chylomicrons. A growing amount of research has indicated that an exaggerated postprandial circulating TG level is a risk indicator for cardiovascular and metabolic disorders. The aim of this research was to identify a botanical extract that inhibits intestinal DGAT1 activity and attenuates postprandial hypertriglyceridemia in overweight and obese humans. Twenty individual phytochemicals and an internal proprietary botanical extract library were screened with a primary cell-free DGAT1 enzyme assay that contained dioleoyl glycerol and palmitoleoyl Coenzyme A as substrates plus human intestinal microsomes as the DGAT1 enzyme source. Botanical extracts with IC50 values &lt; 100 μg/mL were evaluated in a cellular DGAT1 assay. The cellular DGAT1 assay comprised the analysis of (14)C labeled TG synthesis in cells incubated with (14)C-glycerol and 0.3 mM oleic acid. Lead botanical extracts were then evaluated in a parallel, double-blind, placebo-controlled clinical trial. Ninety healthy, overweight and obese participants were randomized to receive 2 g daily of placebo or individual botanical extracts (the investigational product) for seven days. Serum TG levels were measured before and after consuming a high fat meal (HFM) challenge (0.354 L drink/shake; 77 g fat, 25 g carbohydrate and 9 g protein) as a marker of intestinal DGAT1 enzyme activity. Phenolic acids (i.e., gallic acid) and polyphenols (i.e., cyanidin) abundantly found in nature appeared to inhibit DGAT1 enzyme activity in vitro. Four polyphenolic rich botanical extracts were identified from in vitro evaluation in both cell-free and cellular model systems: apple peel extract (APE), grape extract (GE), red raspberry leaf extract (RLE) and apricot/nectarine extract (ANE) (IC50 = 1.4, 5.6, and 10.4 and 3.4 μg/mL, respectively). In the seven day clinical trial, compared to placebo, only GE significantly reduced the baseline subtracted change in serum TG AUC following consumption of the HFM (AUC = 281 ± 37 vs. 181 ± 30 mg/dL*h, respectively; P = 0.021). Chromatographic characterization of the GE revealed a large number of closely eluting components containing proanthocyanidins, catechins, anthocyanins and their secondary metabolites that corresponded with the observed DGAT1 enzyme inhibition in the cell-free model. These data suggest that a dietary GE has the potential to attenuate postprandial hypertriglyceridemia in part by the inhibition of intestinal DGAT1 enzyme activity without intolerable side effects. This trial was registered with ClinicalTrials.gov NCT02333461.</description><identifier>ISSN: 1743-7075</identifier><identifier>EISSN: 1743-7075</identifier><identifier>DOI: 10.1186/s12986-015-0025-2</identifier><identifier>PMID: 26246845</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Anthocyanin ; Care and treatment ; Clinical trials ; Health aspects ; Instrument industry ; Medical research ; Medicine, Botanic ; Medicine, Experimental ; Medicine, Herbal ; Metabolism ; Monounsaturated fatty acids ; Nutrition ; Obesity ; Physiological aspects ; Plant metabolites ; Polyphenols ; Triglycerides</subject><ispartof>Nutrition &amp; metabolism, 2015-08, Vol.12 (1), p.27-27, Article 27</ispartof><rights>COPYRIGHT 2015 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2015</rights><rights>Velliquette et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-b104919f667f6ac15f9417b2da55a5c53a9b7b76c9f4ee1678828279ae3f9d533</citedby><cites>FETCH-LOGICAL-c528t-b104919f667f6ac15f9417b2da55a5c53a9b7b76c9f4ee1678828279ae3f9d533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526202/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1780673773?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26246845$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Velliquette, Rodney A</creatorcontrib><creatorcontrib>Grann, Kerry</creatorcontrib><creatorcontrib>Missler, Stephen R</creatorcontrib><creatorcontrib>Patterson, Jennifer</creatorcontrib><creatorcontrib>Hu, Chun</creatorcontrib><creatorcontrib>Gellenbeck, Kevin W</creatorcontrib><creatorcontrib>Scholten, Jeffrey D</creatorcontrib><creatorcontrib>Randolph, R Keith</creatorcontrib><title>Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trial</title><title>Nutrition &amp; metabolism</title><addtitle>Nutr Metab (Lond)</addtitle><description>Diacylglyceride acyltransferase 1 (DGAT1) is the enzyme that adds the final fatty acid on to a diacylglyceride during triglyceride (TG) synthesis. DGAT1 plays a key role in the repackaging of dietary TG into circulating TG rich chylomicrons. A growing amount of research has indicated that an exaggerated postprandial circulating TG level is a risk indicator for cardiovascular and metabolic disorders. The aim of this research was to identify a botanical extract that inhibits intestinal DGAT1 activity and attenuates postprandial hypertriglyceridemia in overweight and obese humans. Twenty individual phytochemicals and an internal proprietary botanical extract library were screened with a primary cell-free DGAT1 enzyme assay that contained dioleoyl glycerol and palmitoleoyl Coenzyme A as substrates plus human intestinal microsomes as the DGAT1 enzyme source. Botanical extracts with IC50 values &lt; 100 μg/mL were evaluated in a cellular DGAT1 assay. The cellular DGAT1 assay comprised the analysis of (14)C labeled TG synthesis in cells incubated with (14)C-glycerol and 0.3 mM oleic acid. Lead botanical extracts were then evaluated in a parallel, double-blind, placebo-controlled clinical trial. Ninety healthy, overweight and obese participants were randomized to receive 2 g daily of placebo or individual botanical extracts (the investigational product) for seven days. Serum TG levels were measured before and after consuming a high fat meal (HFM) challenge (0.354 L drink/shake; 77 g fat, 25 g carbohydrate and 9 g protein) as a marker of intestinal DGAT1 enzyme activity. Phenolic acids (i.e., gallic acid) and polyphenols (i.e., cyanidin) abundantly found in nature appeared to inhibit DGAT1 enzyme activity in vitro. Four polyphenolic rich botanical extracts were identified from in vitro evaluation in both cell-free and cellular model systems: apple peel extract (APE), grape extract (GE), red raspberry leaf extract (RLE) and apricot/nectarine extract (ANE) (IC50 = 1.4, 5.6, and 10.4 and 3.4 μg/mL, respectively). In the seven day clinical trial, compared to placebo, only GE significantly reduced the baseline subtracted change in serum TG AUC following consumption of the HFM (AUC = 281 ± 37 vs. 181 ± 30 mg/dL*h, respectively; P = 0.021). Chromatographic characterization of the GE revealed a large number of closely eluting components containing proanthocyanidins, catechins, anthocyanins and their secondary metabolites that corresponded with the observed DGAT1 enzyme inhibition in the cell-free model. These data suggest that a dietary GE has the potential to attenuate postprandial hypertriglyceridemia in part by the inhibition of intestinal DGAT1 enzyme activity without intolerable side effects. This trial was registered with ClinicalTrials.gov NCT02333461.</description><subject>Anthocyanin</subject><subject>Care and treatment</subject><subject>Clinical trials</subject><subject>Health aspects</subject><subject>Instrument industry</subject><subject>Medical research</subject><subject>Medicine, Botanic</subject><subject>Medicine, Experimental</subject><subject>Medicine, Herbal</subject><subject>Metabolism</subject><subject>Monounsaturated fatty acids</subject><subject>Nutrition</subject><subject>Obesity</subject><subject>Physiological aspects</subject><subject>Plant metabolites</subject><subject>Polyphenols</subject><subject>Triglycerides</subject><issn>1743-7075</issn><issn>1743-7075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkl1rFDEUhgdRbK3-AG8k4I1CpyaZSTJzUyjFj4WC4Md1yORje0o2WZPs4vrj_G1m3Fq7InOR5JznPcm8vE3znOAzQgb-JhM6DrzFhLUYU9bSB80xEX3XCizYw3v7o-ZJzjcYd10_4sfNEeW050PPjpufC2NDAQdaFYgBRYcUmmJRoVY8gnANE5SY5gaEYnOBUOsGlN75pd9pm8BYNJ9KUiE7m1S2iNRKgS2UHdqCqsq6lBRR1snaAGGJVDD1prVKynvrT1EVm7iCH9acoslDMPNm7ZW2U2x1DFVdQYN07f1-Wkmg_NPmkVM-22e360nz9d3bL5cf2quP7xeXF1etZnQo7URwP5LRcS4cV5owN_ZETNQoxhTTrFPjJCbB9eh6awkXw0AHKkZlOzca1nUnzfl-7nozrazR1bP6cLlOsFJpJ6MCedgJcC2XcSt7Vr3GtA54dTsgxW-baqNcQdbWexVs3GRJBKa8Hzmd0Zf_oDdxk6rrMzVgLjohur_UUnkrIbhY79XzUHnBesI6OvCZOvsPVT9jV1BdtQ5q_UDw-kAwO2-_l6Xa5CwXnz8dsmTP6hRzTtbd-UGwnAMq9wGVNaByDqicf-7FfSPvFH8S2f0CPKXjog</recordid><startdate>20150806</startdate><enddate>20150806</enddate><creator>Velliquette, Rodney A</creator><creator>Grann, Kerry</creator><creator>Missler, Stephen R</creator><creator>Patterson, Jennifer</creator><creator>Hu, Chun</creator><creator>Gellenbeck, Kevin W</creator><creator>Scholten, Jeffrey D</creator><creator>Randolph, R Keith</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150806</creationdate><title>Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trial</title><author>Velliquette, Rodney A ; Grann, Kerry ; Missler, Stephen R ; Patterson, Jennifer ; Hu, Chun ; Gellenbeck, Kevin W ; Scholten, Jeffrey D ; Randolph, R Keith</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-b104919f667f6ac15f9417b2da55a5c53a9b7b76c9f4ee1678828279ae3f9d533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anthocyanin</topic><topic>Care and treatment</topic><topic>Clinical trials</topic><topic>Health aspects</topic><topic>Instrument industry</topic><topic>Medical research</topic><topic>Medicine, Botanic</topic><topic>Medicine, Experimental</topic><topic>Medicine, Herbal</topic><topic>Metabolism</topic><topic>Monounsaturated fatty acids</topic><topic>Nutrition</topic><topic>Obesity</topic><topic>Physiological aspects</topic><topic>Plant metabolites</topic><topic>Polyphenols</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Velliquette, Rodney A</creatorcontrib><creatorcontrib>Grann, Kerry</creatorcontrib><creatorcontrib>Missler, Stephen R</creatorcontrib><creatorcontrib>Patterson, Jennifer</creatorcontrib><creatorcontrib>Hu, Chun</creatorcontrib><creatorcontrib>Gellenbeck, Kevin W</creatorcontrib><creatorcontrib>Scholten, Jeffrey D</creatorcontrib><creatorcontrib>Randolph, R Keith</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Science (Gale in Context)</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nutrition &amp; metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Velliquette, Rodney A</au><au>Grann, Kerry</au><au>Missler, Stephen R</au><au>Patterson, Jennifer</au><au>Hu, Chun</au><au>Gellenbeck, Kevin W</au><au>Scholten, Jeffrey D</au><au>Randolph, R Keith</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trial</atitle><jtitle>Nutrition &amp; metabolism</jtitle><addtitle>Nutr Metab (Lond)</addtitle><date>2015-08-06</date><risdate>2015</risdate><volume>12</volume><issue>1</issue><spage>27</spage><epage>27</epage><pages>27-27</pages><artnum>27</artnum><issn>1743-7075</issn><eissn>1743-7075</eissn><abstract>Diacylglyceride acyltransferase 1 (DGAT1) is the enzyme that adds the final fatty acid on to a diacylglyceride during triglyceride (TG) synthesis. DGAT1 plays a key role in the repackaging of dietary TG into circulating TG rich chylomicrons. A growing amount of research has indicated that an exaggerated postprandial circulating TG level is a risk indicator for cardiovascular and metabolic disorders. The aim of this research was to identify a botanical extract that inhibits intestinal DGAT1 activity and attenuates postprandial hypertriglyceridemia in overweight and obese humans. Twenty individual phytochemicals and an internal proprietary botanical extract library were screened with a primary cell-free DGAT1 enzyme assay that contained dioleoyl glycerol and palmitoleoyl Coenzyme A as substrates plus human intestinal microsomes as the DGAT1 enzyme source. Botanical extracts with IC50 values &lt; 100 μg/mL were evaluated in a cellular DGAT1 assay. The cellular DGAT1 assay comprised the analysis of (14)C labeled TG synthesis in cells incubated with (14)C-glycerol and 0.3 mM oleic acid. Lead botanical extracts were then evaluated in a parallel, double-blind, placebo-controlled clinical trial. Ninety healthy, overweight and obese participants were randomized to receive 2 g daily of placebo or individual botanical extracts (the investigational product) for seven days. Serum TG levels were measured before and after consuming a high fat meal (HFM) challenge (0.354 L drink/shake; 77 g fat, 25 g carbohydrate and 9 g protein) as a marker of intestinal DGAT1 enzyme activity. Phenolic acids (i.e., gallic acid) and polyphenols (i.e., cyanidin) abundantly found in nature appeared to inhibit DGAT1 enzyme activity in vitro. Four polyphenolic rich botanical extracts were identified from in vitro evaluation in both cell-free and cellular model systems: apple peel extract (APE), grape extract (GE), red raspberry leaf extract (RLE) and apricot/nectarine extract (ANE) (IC50 = 1.4, 5.6, and 10.4 and 3.4 μg/mL, respectively). In the seven day clinical trial, compared to placebo, only GE significantly reduced the baseline subtracted change in serum TG AUC following consumption of the HFM (AUC = 281 ± 37 vs. 181 ± 30 mg/dL*h, respectively; P = 0.021). Chromatographic characterization of the GE revealed a large number of closely eluting components containing proanthocyanidins, catechins, anthocyanins and their secondary metabolites that corresponded with the observed DGAT1 enzyme inhibition in the cell-free model. These data suggest that a dietary GE has the potential to attenuate postprandial hypertriglyceridemia in part by the inhibition of intestinal DGAT1 enzyme activity without intolerable side effects. This trial was registered with ClinicalTrials.gov NCT02333461.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>26246845</pmid><doi>10.1186/s12986-015-0025-2</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1743-7075
ispartof Nutrition & metabolism, 2015-08, Vol.12 (1), p.27-27, Article 27
issn 1743-7075
1743-7075
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4526202
source Publicly Available Content Database; PubMed Central
subjects Anthocyanin
Care and treatment
Clinical trials
Health aspects
Instrument industry
Medical research
Medicine, Botanic
Medicine, Experimental
Medicine, Herbal
Metabolism
Monounsaturated fatty acids
Nutrition
Obesity
Physiological aspects
Plant metabolites
Polyphenols
Triglycerides
title Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A04%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20a%20botanical%20inhibitor%20of%20intestinal%20diacylglyceride%20acyltransferase%201%20activity%20via%20in%20vitro%20screening%20and%20a%20parallel,%20randomized,%20blinded,%20placebo-controlled%20clinical%20trial&rft.jtitle=Nutrition%20&%20metabolism&rft.au=Velliquette,%20Rodney%20A&rft.date=2015-08-06&rft.volume=12&rft.issue=1&rft.spage=27&rft.epage=27&rft.pages=27-27&rft.artnum=27&rft.issn=1743-7075&rft.eissn=1743-7075&rft_id=info:doi/10.1186/s12986-015-0025-2&rft_dat=%3Cgale_pubme%3EA541532863%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c528t-b104919f667f6ac15f9417b2da55a5c53a9b7b76c9f4ee1678828279ae3f9d533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1780673773&rft_id=info:pmid/26246845&rft_galeid=A541532863&rfr_iscdi=true